GlassScriptPhysician profile
Elisabeth Ann Stump
NPI 1255826947
$1,608.71
in general payments reported to CMS, 2019-2025
18 companies · $458 in 2025
The $458 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $143 · 2022: $176 · 2023: $27.75 · 2024: $804 · 2025: $458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $892 · Travel and Lodging: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $892.35 |
| Travel and Lodging | $397.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $897.89 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $165.00 | 2024-2025 | Exparel, Iovera, Zilretta |
| Aspira Women'S Health INC | $105.40 | 2022 | |
| Hologic Sales and Service, LLC | $65.39 | 2024-2025 | Novasure, Myosure Tissue Removal Device, Magseed |
| Masimo Corporation | $62.64 | 2021 | |
| Abbvie INC. | $42.44 | 2021-2022 | |
| Stryker Corporation | $36.51 | 2024 | 1788 |
| Davol INC. | $35.87 | 2025 | Phasix Mesh |
| Pfizer INC. | $34.82 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.75 | 2023 | Gattex |
| Astrazeneca Pharmaceuticals LP | $22.87 | 2024 | Tagrisso |
| Merck Sharp & Dohme LLC | $19.50 | 2025 | Keytruda |
| Exact Sciences Corporation | $19.28 | 2024 | Cologuard Collection Kit |
| Renovia INC | $18.00 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $17.70 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $13.46 | 2022 | |
| Exeltis, USA INC. | $12.10 | 2021 | |
| Mylan Pharmaceuticals INC. | $12.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elisabeth Stump listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.